Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/1999
08/19/1999WO1999041375A2 Human receptor proteins
08/19/1999WO1999041369A2 Genetic vaccine vector engineering
08/19/1999WO1999041368A2 Optimization of immunomodulatory properties of genetic vaccines
08/19/1999WO1999041363A1 Podocalyxin like sialomucins having selectin ligand activity
08/19/1999WO1999041286A1 DERIVATISED ANTIBODIES WITH EXPOSED CARBOHYDRATE CHAINS CAPABLE OF BINDING TO IMMOBILISED IgG
08/19/1999WO1999041285A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
08/19/1999WO1999041283A1 Pf4 fragments and pharmaceutical compositions containing same
08/19/1999WO1999041267A1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives
08/19/1999WO1999041257A1 Glucocorticoid-selective antiinflammatory agents
08/19/1999WO1999041246A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
08/19/1999WO1999041240A1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors
08/19/1999WO1999041224A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
08/19/1999WO1999040943A1 Solubilizing delivery systems and method of manufacture
08/19/1999WO1999040914A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
08/19/1999WO1999040913A1 Chemical compounds
08/19/1999WO1999040910A1 Anti-inflammatory agents
08/19/1999WO1999040909A1 Method for modulating macrophage activation
08/19/1999WO1999040906A2 Method and composition for treatment of inflammatory conditions
08/19/1999WO1999030670A3 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
08/19/1999WO1999024024A3 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists
08/19/1999WO1999023108A9 Inducible phosphofructokinase and the warburg effect
08/19/1999WO1998008966A8 Loxoprofen-containing preparation for external use
08/19/1999DE19806348A1 3,4-Dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln 3,4-dihydroquinoline derivatives and their use in medicaments
08/19/1999CA2632106A1 Method for modulating macrophage activation
08/19/1999CA2321277A1 Derivatised antibodies with exposed carbohydrate chains capable of binding to immobilised igg
08/19/1999CA2321136A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
08/19/1999CA2320960A1 Optimization of immunomodulatory properties of genetic vaccines
08/19/1999CA2320911A1 Glucocorticoid-selective anti-inflammatory agents
08/19/1999CA2320626A1 Genetic vaccine vector engineering
08/19/1999CA2320431A1 Targeting of genetic vaccine vectors
08/19/1999CA2320427A1 Human receptor proteins
08/19/1999CA2320285A1 Anti-inflammatory agents
08/19/1999CA2319173A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
08/19/1999CA2319082A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
08/19/1999CA2319009A1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives
08/19/1999CA2318966A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
08/19/1999CA2318068A1 Podocalyxin like sialomucins having selectin ligand activity
08/19/1999CA2317456A1 Chemical compounds
08/18/1999EP0935963A2 The use of MMP-13 selective inhibitors for the treatment of osteoarthritis and other matrix metalloproteinase-mediated disorders
08/18/1999EP0935601A2 Arylamino fused pyridines and pyrimidines
08/18/1999EP0935465A1 Novel substituted imidazole compounds
08/18/1999EP0935463A2 Anti-neurogenic inflammatory compounds and compositions and methods of use thereof
08/18/1999EP0896537B1 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide
08/18/1999EP0796257B1 Malonic acid based matrix metalloproteinase inhibitors
08/18/1999EP0759026B1 Amide derivatives and their therapeutic use
08/18/1999EP0682662B1 Bicyclic carboxylic acid leukotriene b4 antagonists
08/18/1999CN1226254A Method and composition useful for inhibition of vasculogenesis of alpha, beta medium
08/18/1999CN1225834A Liniment
08/17/1999US5939583 Antiarthritic agents; bone, cardiovascular, brain, nervous system disorders; antitumor and antimetastasis agents
08/17/1999US5939525 Methods of treating inflammation and compositions therefor
08/17/1999US5939452 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4' (LTB4) antagonists
08/17/1999US5939450 N,N-dimethyl-8,8-dipropyl-2-azaspiro 4.5!decane-2-propanamine dimaleate
08/17/1999US5939434 Tetrazolyl-substituted quinuclidines as substance P antagonists
08/17/1999US5939433 Quinuclidine derivatives
08/17/1999US5939432 Thiophenes useful for modulating the adenosine receptor
08/17/1999US5939427 Lotion with 17-allyl-1,4-dihydroxy-12-(2-(4-hydroxy-3-methoxy cyclohexyl)-1-methylvinyl)-23,25-dimethoxy-13,19,21,27-tetrame thyl-11,28-dioxa-4-azatricyclo(22.3.1.0(4,9))octacos-18-ene-1, 3,10,16-tetraone or salt as antiinflammatory agent
08/17/1999US5939422 An enzyme inhibitor as bronchodilator, relaxants, antiinflammatory agent for treating asthma, allergies, inflammation, depression, dementia, diseases associated with abnormal high level of cytokine
08/17/1999US5939415 A!-annellated pyrrole derivatives and their use in pharmacology
08/17/1999US5939413 Tachykinin mediated diseases in humans for respiratory system disorders like asthma, bronchitis, rhinitis or eye diseases or skin disorders
08/17/1999US5939411 Piperidine derivatives substituted at position 4 with new functions other than those described previously have a high affinity for neurokinin receptors and are useful for treatment of substance p and neurokinin dependent pathologies
08/17/1999US5939409 Processes for the production of anti-inflammatory steroids
08/17/1999US5939400 DNA vaccination for induction of suppressive T cell response
08/17/1999US5939392 Thrombin inhibitors, anticoagulants and antiinflammatory agents
08/17/1999US5939389 Use of C1-inactivation for therapy of certain diseases
08/17/1999CA2136824C Phosponocarboxylate compounds for treating abnormal calcium and phosphate metabolism
08/16/1999CA2247994A1 Solubilizing delivery systems and method of manufacture
08/16/1999CA2247877A1 Solubilizing delivery systems and method of manufacture
08/12/1999WO1999040201A1 Protein
08/12/1999WO1999040196A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same
08/12/1999WO1999040184A1 Dendritic enriched secreted lymphocyte activation molecule
08/12/1999WO1999040183A1 Human serine protease and serpin polypeptides
08/12/1999WO1999040117A1 THREE-DIMENSIONAL STRUCTURES AND MODELS OF Fc RECEPTORS AND USES THEREOF
08/12/1999WO1999040115A2 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT
08/12/1999WO1999040091A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
08/12/1999WO1999040089A1 Benzothiadiazoles and derivatives
08/12/1999WO1999040088A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors
08/12/1999WO1999040085A1 Benzofuran-4-carboxamides and their therapeutic use
08/12/1999WO1999040083A2 Bifunctional tryptase inhibitors
08/12/1999WO1999040080A1 Hydroxamic and carboxylic acid derivatives
08/12/1999WO1999040073A2 Tryptase inhibitors
08/12/1999WO1999040061A2 Novel dihydroxyhexanoic acid derivatives
08/12/1999WO1999039737A1 Preventives/remedies for inflammatory intestinal disease
08/12/1999WO1999039682A2 Lipid mixtures and their use
08/12/1999WO1999029339A3 Prevention and/or treatment of allergic conditions
08/12/1999WO1999028344A3 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
08/12/1999WO1999028304A3 Pdgf receptor kinase inhibitory compounds, their preparation and compositions
08/12/1999WO1999022761A9 Conjugate heat shock protein-binding peptides
08/12/1999WO1999003446A3 Antimicrobial cosmetic compositions
08/12/1999WO1999000116A3 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
08/12/1999CA2321025A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors
08/12/1999CA2320098A1 Compositions and methods to inhibit formation of the c5b-9 complex of complement
08/12/1999CA2319644A1 Human serine protease and serpin polypeptides
08/12/1999CA2319421A1 Preventives/remedies for inflammatory intestinal disease
08/12/1999CA2319236A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same
08/12/1999CA2319097A1 Dendritic enriched secreted lymphocyte activation molecule
08/12/1999CA2318977A1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines
08/12/1999CA2317478A1 Benzofuran-4-carboxamides and their therapeutic use
08/12/1999CA2317476A1 Hydroxamic and carboxylic acid derivatives
08/12/1999CA2316860A1 Three-dimensional structures and models of fc receptors and uses thereof
08/12/1999CA2310041A1 Lipid mixtures and their use
1 ... 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 ... 1272